menu
techminis

A naukri.com initiative

google-web-stories
Home

>

Bio News

>

Who Should...
source image

Bioengineer

3d

read

282

img
dot

Image Credit: Bioengineer

Who Should Take Statins? A New Study Compares Traditional Risk Factors to Coronary Artery Calcium Scoring in Prescribing Recommendations

  • A new study led by Intermountain Health compares coronary artery calcium scoring to traditional risk factors in determining statin therapy recommendations for coronary heart disease prevention.
  • The study challenges the conventional risk assessment model, Pooled Cohort Equations, by incorporating non-invasive coronary artery calcium scoring to evaluate atherosclerotic plaque burden.
  • Early findings suggest a significant difference in statin therapy recommendations between the two assessment methods, with CAC scoring resulting in fewer prescriptions.
  • This disparity highlights potential over-prescription of statins based on traditional risk factors, especially in older populations, leading to unnecessary medication use and associated risks.
  • Identifying patients who truly benefit from statin therapy is crucial to avoid adverse effects such as muscle discomfort and metabolic risks like diabetes.
  • The study's unveiling at the American College of Cardiology's Annual Scientific Sessions signifies a shift towards more individualized and evidence-based treatment strategies in cardiovascular medicine.
  • The research aims to influence clinical practices by providing insights into long-term outcomes and guiding refined treatment plans for heart disease prevention.
  • This comprehensive investigation into PCE versus CAC scores represents a distinct step towards personalized preventive care in cardiology and signifies a significant advancement in cardiovascular medicine.
  • Understanding the nuances of coronary health assessments can lead to a reduction in the societal burden of heart disease and improve individualized care in managing cardiovascular risks.
  • The study's focus on efficient statin prescription, based on accurate risk identification, marks a pivotal progression in preventive cardiology and reshapes the landscape of heart health care.

Read Full Article

like

16 Likes

For uninterrupted reading, download the app